{"database": "openregs", "table": "documents", "rows": [["DEA-2017-0003-0014", "DEA", "DEA-2017-0003", "Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC)]in Schedule II", "Rule", null, "2017-11-22T05:00:00Z", 2017, 11, null, null, "2017-11-22T13:21:09Z", "2017-25275", 0, 0, "0900006482c9ed02"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["DEA-2017-0003-0014"], "units": {}, "query_ms": 1.977521926164627, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}